95
Views
12
CrossRef citations to date
0
Altmetric
Mini Review

Role of CCR5 Δ32 bp deletion in RA and SLE

, &
Pages 260-262 | Received 09 Sep 2008, Accepted 07 Jan 2009, Published online: 13 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Fa-Juan Cheng, Xu-Jie Zhou, Yan-Feng Zhao, Ming-Hui Zhao & Hong Zhang. (2014) Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: A large case-control study and meta-analysis. Autoimmunity 47:6, pages 383-388.
Read now
Giulia Pazzola, Luigi Boiardi, Bruno Casali, Enrico Farnetti, Davide Nicoli, Nicolò Pipitone, Ilaria Padovano, Andrea Caruso, Mariagrazia Catanoso & Carlo Salvarani. (2013) CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis. Modern Rheumatology 23:5, pages 851-855.
Read now

Articles from other publishers (10)

Juliana da Silveira Schauren, Amanda Henrique de Oliveira, Camila Rosat Consiglio, Odirlei André Monticielo, Ricardo Machado Xavier, Natália Schneider Nunes, Joel Henrique Ellwanger & José Artur Bogo Chies. (2023) CCR5 promoter region polymorphisms in systemic lupus erythematosus . International Journal of Immunogenetics.
Crossref
Ewa Rzeszotarska, Anna Sowinska, Barbara Stypinska, Ewa Walczuk, Anna Wajda, Anna Lutkowska, Anna Felis-Giemza, Marzena Olesinska, Mariusz Puszczewicz, Dominik Majewski, Pawel Piotr Jagodzinski, Michal Czerewaty, Damian Malinowski, Andrzej Pawlik, Malgorzata Jaronczyk & Agnieszka Paradowska-Gorycka. (2020) The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus. Biomolecules 10:3, pages 494.
Crossref
You‐Yu Lan, You‐Qiang Wang & Yi Liu. (2019) Retracted : CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway . Journal of Cellular Physiology 234:10, pages 18748-18762.
Crossref
C. Carvalho, S. L. Calvisi, B. Leal, A. Bettencourt, A. Marinho, I. Almeida, F. Farinha, P. P. Costa, B. M. Silva & C. Vasconcelos. (2014) CCR5-Delta32: implications in SLE development. International Journal of Immunogenetics 41:3, pages 236-241.
Crossref
Anna Junker, Dirk Schepmann, Junichiro Yamaguchi, Kenichiro Itami, Andreas Faust, Klaus Kopka, Stefan Wagner & Bernhard Wünsch. (2014) Diverse modifications of the 4-methylphenyl moiety of TAK-779 by late-stage Suzuki–Miyaura cross-coupling. Org. Biomol. Chem. 12:1, pages 177-186.
Crossref
Anna Junker, Artur Kamil Kokornaczyk, Ann Kathrin Strunz & Bernhard Wünsch. 2015. Chemokines. Chemokines 187 241 .
JS Schauren, JA Marasca, TD Veit, OA Monticielo, RM Xavier, JCT Brenol & JAB Chies. (2013) CCR5delta32 in systemic lupus erythematosus: implications for disease susceptibility and outcome in a Brazilian population. Lupus 22:8, pages 802-809.
Crossref
F. David Carmona, Luis Rodríguez-Rodríguez, Santos Castañeda, José A. Miranda-Filloy, Inmaculada C. Morado, Javier Narváez, Beatriz Marí-Alfonso, Ainhoa Unzurrunzaga, Raquel Ríos-Fernández, Ricardo Blanco, Eugenio de Miguel, Javier Martín & Miguel A. González-Gay. (2011) Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis. Human Immunology 72:5, pages 458-461.
Crossref
Mohammad Kazemi Arababadi, Ali Akbar Pourfathollah, Abdollah Jafarzadeh, Gholamhossein Hassanshahi, Maryam Mohit, Masomeh Hajghani, Behzad Nasiri Ahmadabadi & Derek Kennedy. (2010) Evaluation of CCR5 Expression on NK Cells in Iranian Patients With Occult Hepatitis B Infection. Laboratory Medicine 41:12, pages 735-738.
Crossref
Hervé C. Gérard, Jessica A. Stanich, Cynthia E. Oszust, Judith A. Whittum-Hudson, Alan P. Hudson, John D. Carter & H. Ralph Schumacher. (2010) Functional CCR5 Receptor Protects Patients With Arthritis From High Synovial Burden of Infecting Chlamydia trachomatis. The American Journal of the Medical Sciences 340:6, pages 448-451.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.